2m 2m 2m 2m 2m 2m 2m
Aurinia Pharma (AUPH)
NASDAQ
$14.75-$0.13 (-0.85%)
Price as of Aug 03, 2026 10:21 AM EDT- $1.9BMarket Cap
- 41.85%1-Year Change
- BiotechnologyIndustry
Aurinia Pharma (AUPH)
$14.75-$0.13 (-0.85%)
AUPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.88 | ||
Change | -$0.12 (-0.80%) | ||
Open | $14.80 | ||
High | $15.25 | ||
Low | $14.36 | ||
Previous Close | $15.00 | ||
Volume | 1,655,486 | ||
30-Day Average Volume | 1,333,469 | ||
1-Week Change | -3.06% | ||
1-Month Change | -12.32% | ||
1-Year Change | 41.85% | ||
3-Year Change | 28.50% | ||
5-Year Change | 9.73% | ||
Fundamentals | |||
Shares Outstanding | 128.6M | ||
Total Assets | $724.0M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $73.6M | ||
Net Income | $34.4M | ||
Free Cash Flow | $8.9M | ||
EBIT | $43.9M | ||
EBITDA | $48.7M | ||
Net Working Capital | $393.7M | ||
EPS | $0.25 | ||
Enterprise Value/EBITDA | 38 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 3 | ||
P/E | 60 | ||
PEG | -1 | ||
Price/Free Cash Flow | 216 | ||
Price/Operating Cash Flow | 59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue